Nemaura Medical Inc
Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factor… Read more
Market Cap & Net Worth: Nemaura Medical Inc (NMRD)
Nemaura Medical Inc (PINK:NMRD) has a market capitalization of $8.07K ($8.07K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #46988 globally and #14579 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nemaura Medical Inc's stock price $0.00 by its total outstanding shares 40351702 (40.35 Million).
Nemaura Medical Inc Market Cap History: 2015 to 2025
Nemaura Medical Inc's market capitalization history from 2015 to 2025. Data shows change from $706.15 Million to $8.07K (-63.51% CAGR).
Nemaura Medical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nemaura Medical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
114.70x
Nemaura Medical Inc's market cap is 114.70 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $69.29 Million | $503.91K | -$13.89 Million | 137.50x | N/A |
| 2023 | $8.84 Million | $77.04K | -$14.14 Million | 114.70x | N/A |
Competitor Companies of NMRD by Market Capitalization
Companies near Nemaura Medical Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Nemaura Medical Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Nemaura Medical Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Nemaura Medical Inc's market cap moved from $706.15 Million to $ 8.07K, with a yearly change of -63.51%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $8.07K | 0.00% |
| 2024 | $8.07K | -99.91% |
| 2023 | $8.84 Million | -87.25% |
| 2022 | $69.29 Million | -62.34% |
| 2021 | $184.00 Million | +20.95% |
| 2020 | $152.13 Million | +7.71% |
| 2019 | $141.23 Million | -61.11% |
| 2018 | $363.17 Million | -82.35% |
| 2017 | $2.06 Billion | +240.00% |
| 2016 | $605.28 Million | -14.29% |
| 2015 | $706.15 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Nemaura Medical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.07K USD |
| MoneyControl | $8.07K USD |
| MarketWatch | $8.07K USD |
| marketcap.company | $8.07K USD |
| Reuters | $8.07K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.